Jade Biosciences Ownership | Who Owns Jade Biosciences?
Jade Biosciences Ownership Summary
Jade Biosciences is owned by 126.30% institutional investors, 0.79% insiders. Fmr is the largest institutional shareholder, holding 15.80% of JBIO shares. Franklin US Small Cap Value Equity is the top mutual fund, with 3.65% of its assets in Jade Biosciences shares.
JBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Jade Biosciences | 126.30% | 0.79% | -27.10% |
| Sector | Healthcare Stocks | 245.07% | 12.10% | -157.17% |
| Industry | Biotech Stocks | 380.48% | 11.73% | -292.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 9.13M | 15.80% | $202.80M |
| Janus henderson group | 3.11M | 9.90% | $43.56M |
| Fairmount funds management | 4.55M | 7.88% | $101.18M |
| Ra capital management | 3.67M | 6.35% | $81.57M |
| Vr adviser | 3.22M | 5.57% | $71.56M |
| Vanguard group | 2.10M | 5.29% | $32.34M |
| Bellevue group | 3.06M | 5.29% | $67.95M |
| Paradigm biocapital advisors lp | 2.86M | 4.95% | $63.49M |
| Blackrock funding, inc. /de | 2.80M | 4.85% | $62.25M |
| Franklin resources | 2.79M | 4.83% | $62.04M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 991.78K | 13.55% | $22.04M |
| Fairmount funds management | 4.55M | 6.69% | $101.18M |
| Avidity partners management lp | 1.70M | 6.05% | $37.79M |
| Acorn capital advisors | 986.76K | 5.98% | $21.93M |
| Foresite capital management vi | 886.67K | 3.07% | $19.70M |
| Vr adviser | 3.22M | 2.17% | $71.56M |
| Bellevue group | 3.06M | 1.43% | $67.95M |
| Samsara biocapital | 736.24K | 1.34% | $16.36M |
| Verdad advisers, lp | 56.38K | 1.20% | $1.25M |
| Paradigm biocapital advisors lp | 2.86M | 1.19% | $63.49M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 3.11M | 0.02% | 3.11M |
| Paradigm biocapital advisors lp | 2.86M | 1.19% | 2.86M |
| Franklin resources | 2.79M | 0.01% | 2.79M |
| Fmr | 9.13M | 0.01% | 2.04M |
| Adage capital partners gp | 1.91M | 0.06% | 1.91M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -2.28M |
| Frazier life sciences management | - | - | -1.41M |
| Great point partners | - | - | -964.46K |
| Driehaus capital management | - | - | -635.50K |
| Rtw investments, lp | - | - | -573.21K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Janus henderson group | 3.11M | 0.02% | 3.11M | $43.56M |
| Paradigm biocapital advisors lp | 2.86M | 1.19% | 2.86M | $63.49M |
| Franklin resources | 2.79M | 0.01% | 2.79M | $62.04M |
| Adage capital partners gp | 1.91M | 0.06% | 1.91M | $42.46M |
| Polar capital | 1.85M | 0.10% | 1.85M | $41.04M |
Sold Out
| Holder | Change |
|---|---|
| Root financial partners | -1.00 |
| Principal securities | -5.00 |
| Mai capital management | -6.00 |
| Glenmede investment management, lp | -53.00 |
| Simplex trading | -83.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 157 | 27.64% | 72,973,653 | 46.40% | 126 | 1.70% | 115 | 74.24% | 24 | -31.43% |
| Mar 31, 2026 | 62 | -41.51% | 12,616,762 | -73.20% | 40 | 0.28% | 32 | -59.49% | 21 | 61.54% |
| Dec 31, 2025 | 75 | -1.32% | 20,804,363 | -34.20% | 52 | 0.82% | 55 | 77.42% | 10 | -54.55% |
| Sep 30, 2025 | 29 | -59.15% | 6,448,004 | -79.55% | 22 | 0.18% | 9 | -87.14% | 14 | - |
| Jun 30, 2025 | 32 | - | 6,707,208 | - | 134,144 | - | 32 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin US Small Cap Value Equity | 2.32M | 3.65% | 1.83M |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.70M | 2.79% | 284.01K |
| Vanguard Total Stock Mkt Idx Inv | 1.70M | 2.79% | 284.01K |
| State Street® SPDR® S&P® Biotech ETF | 1.76M | 2.77% | 19.80K |
| Polar Capital Biotech S Inc | 1.75M | 2.75% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.70M | 2.67% | - |
| Fidelity Growth Compy Commingled Pl S | 1.63M | 2.67% | 242.10K |
| Franklin Small Cap Value A | 1.63M | 2.56% | 215.98K |
| Fidelity Growth Company Fund | 1.19M | 1.87% | - |
| iShares Russell 2000 ETF | 1.04M | 1.64% | 8.93K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Frohlich Tom | Chief Executive Officer | Buy | $44.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
JBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools